cCAT expression status was further reported by Feld et al. as an independent prognostic marker of pancreatic ductal adenocarcinoma, allowing the stratification of patients in subgroups with a median OS variation of approximately 6 months, in which patients with cCAT-positive tumors presented a significantly longer OS and earlier stage of the disease [51]. Here, GOT1 is linked to pancreatic ductal adenocarcinoma.